Document Detail


Enhanced cardiovascular morbidity and mortality during rhythm control treatment in persistent atrial fibrillation in hypertensives: data of the RACE study.
MedLine Citation:
PMID:  17272359     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIM: To investigate the influence of hypertension on morbidity and mortality during rate and rhythm control in patients with persistent atrial fibrillation (AF). METHODS AND RESULTS: In the RAte Control vs. Electrical cardioversion (RACE) study, 522 patients (256 with hypertension) were randomized to rate or rhythm control. The occurrence of cardiovascular morbidity and mortality was compared between patients with and without hypertension. Patients with hypertension were older (69 +/- 8 vs. 67 +/- 9 years, P = 0.01), more female (P < 0.001), had more diabetes (P = 0.005), a higher CHADS(2) score (2.2 +/- 1.0 vs. 1.0 +/- 0.9, P < 0.001), and higher systolic and diastolic blood pressures. Septal and posterior wall thicknesses were higher in hypertensives. Complaints related to AF were similar. After a median follow-up of 2.4 (range 0-3.4) years more endpoints occurred in hypertensives (25 vs. 15%). Randomized treatment strategy, i.e. rate or rhythm control, influenced the occurrence of the primary endpoint only in hypertensives. Hypertensives treated with rhythm control experienced most endpoints (incidence rates/100 person-years 13.3 vs. 7.2, relative risk 0.5 [0.3-0.9], P = 0.02), mainly thromboembolic complications, adverse effects of antiarrhythmics, and pacemaker implantations. CONCLUSION: In persistent AF patients with hypertension, a pharmacological rhythm control approach is associated with enhanced cardiovascular morbidity and mortality. Therefore, rate-control strategy should be considered in these patients.
Authors:
Michiel Rienstra; Dirk J Van Veldhuisen; Harry J G M Crijns; Isabelle C Van Gelder;
Related Documents :
22452499 - Effect of head and neck position on intrathoracic pressure and arterial blood gas value...
16669409 - Markers of vascular inflammation are associated with the extent of atherosclerosis asse...
22465189 - Negative pressure pulmonary oedema after septoplasty.
18172059 - Effects of candesartan compared with amlodipine in hypertensive patients with high card...
11162339 - Blood pressure and cardiovascular morbidity and mortality in a dutch population: the ni...
12107419 - The 2001 canadian recommendations for the management of hypertension: part one--assessm...
6470379 - Anorectal manometry in healthy elderly subjects.
14638619 - Hypertension treatment and control in five european countries, canada, and the united s...
9272189 - An abnormal relationship between blood pressure and pulse rate in amyotrophic lateral s...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2007-02-01
Journal Detail:
Title:  European heart journal     Volume:  28     ISSN:  0195-668X     ISO Abbreviation:  Eur. Heart J.     Publication Date:  2007 Mar 
Date Detail:
Created Date:  2007-03-16     Completed Date:  2008-02-05     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8006263     Medline TA:  Eur Heart J     Country:  England    
Other Details:
Languages:  eng     Pagination:  741-51     Citation Subset:  IM    
Affiliation:
Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Anticoagulants / therapeutic use
Atrial Fibrillation / complications,  mortality,  physiopathology,  therapy*
Blood Pressure / physiology
Electric Countershock / methods*
Female
Heart Failure / etiology
Humans
Hypertension / complications*,  mortality,  physiopathology
Male
Thromboembolism / etiology
Treatment Outcome
Chemical
Reg. No./Substance:
0/Anticoagulants

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Application of a new algorithm in the differential diagnosis of wide QRS complex tachycardia.
Next Document:  Prenatal diagnosis and normal outcome of a 46,XX/46,XY chimera: a case report.